Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Canadian Healthcare Providers’ Attitudes Towards Automated Insulin Delivery Systems

View ORCID ProfileAmy E Morrison, Kate Farnsworth, View ORCID ProfileHolly O Witteman, Anna Lam, Peter A Senior
doi: https://doi.org/10.1101/2022.06.02.22275169
Amy E Morrison
1University of Alberta, Division of Endocrinology and Metabolism, Department of Medicine, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amy E Morrison
  • For correspondence: amymorrison15{at}doctors.org.uk
Kate Farnsworth
2Diabetes Action Canada, Innovations in T1D, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Holly O Witteman
3Université Laval, Department of Family and Emergency Medicine and Office of Education and Professional Development, Québec City, Québec, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Holly O Witteman
Anna Lam
1University of Alberta, Division of Endocrinology and Metabolism, Department of Medicine, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter A Senior
1University of Alberta, Division of Endocrinology and Metabolism, Department of Medicine, Edmonton, Alberta, Canada
2Diabetes Action Canada, Innovations in T1D, Toronto, Ontario, Canada
4Alberta Diabetes Institute, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction We aimed to assess the current experience and attitudes towards Commercial and Do-it-yourself (DIY) automated insulin delivery (AID) systems among healthcare providers (HCP) across Canada.

Methods A cross-sectional study was performed through electronic distribution of an anonymous survey to HCP licensed to practice in Canada looking after people with type 1 diabetes (T1D).

Results Responses included 204 HCP across the multi-disciplinary team; dieticians (32.8%), nurses (31.9%), and endocrinologists (28.4%), looking after adults (51%) and children (23%) mainly in urban areas (85.7%). Respondents reported a median 100-500 patients with T1D per practice, with a median 6-24 current users/practice of Commercial compared to a median 1-5 current users/practice of DIY AID. The majority of HCP (72.7%) were comfortable supporting Commercial AID, whereas only 21.6% reported comfort supporting DIY AID use. A significant, although moderate correlation between HCP experience and comfort was seen; Commercial r=0.57(p<0.0001) and DIY r=0.45(p<0.0001). Respondents reported more barriers to DIY, relative to Commercial AID(p=0.001); unfamiliarity/lack of exposure and medico-legal risks were highlighted with DIY systems. Respondents suggested AID system education (both Commercial and DIY), for HCP and users, to improve HCP confidence.

Conclusions Despite documented beneficial outcomes, AID systems are not widely used in the management of T1D in Canada. The need for both user and HCP education to improve familiarity with the systems, in addition to clarity in medico-legal guidance, have been identified as gaps, which if addressed, might enable the benefits of AID to be more widely available to people with T1D in Canada.

Competing Interest Statement

KF is a full-time employee of Beta Bionics and all the research associated with CANADIAN HEALTHCARE PROVIDERS' ATTITUDES TOWARDS AUTOMATED INSULIN DELIVERY SYSTEMS was completed in her capacity prior to her employment with Beta Bionics and as an independent consultant. The opinions/views expressed in this presentation/publication are her own. They do not purport to reflect the opinions or views of the Beta Bionics, its employees, agents, investors and/or board members or its members. HOW has received grants from Canadian Institutes of Health Research, Diabetes Action Canada, Canada Foundation for Innovation and Fonds de recherche du Quebec-Sante. HOW personally uses a Do-It-Yourself system. AL has received grants from Juvenile Diabetes Research Foundation and Diabetes UK. PAS has received grants from Novo Nordisk and is a Board chair for Diabetes Canada and Co-Investigator Diabetes Action Canada.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research Ethics Board of University of Alberta gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 03, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Canadian Healthcare Providers’ Attitudes Towards Automated Insulin Delivery Systems
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Canadian Healthcare Providers’ Attitudes Towards Automated Insulin Delivery Systems
Amy E Morrison, Kate Farnsworth, Holly O Witteman, Anna Lam, Peter A Senior
medRxiv 2022.06.02.22275169; doi: https://doi.org/10.1101/2022.06.02.22275169
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Canadian Healthcare Providers’ Attitudes Towards Automated Insulin Delivery Systems
Amy E Morrison, Kate Farnsworth, Holly O Witteman, Anna Lam, Peter A Senior
medRxiv 2022.06.02.22275169; doi: https://doi.org/10.1101/2022.06.02.22275169

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)